secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prelude Therapeutics Inc (PRLD)
CIK:        0001678660
Form:       8-K
Filed at:   2023-01-09T23:59:59+00:00
Accession:  0000950170-23-000439
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prelude Therapeutics files corporate presentation; no specific new details provided
--------------------------------------------------------------------------------

- Prelude Therapeutics made a corporate presentation available to investors on January 9, 2023.
- The presentation was furnished under Regulation FD but its substantive content was not disclosed.
- No changes to revenue, EPS, pipeline status, or corporate strategy were announced.
- The filing does not contain any new material information beyond the existence of the presentation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1678660/000095017023000439/0000950170-23-000439-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1678660/000095017023000439/prld-20230109.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-000439

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer